Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study

Summary

The purpose of the MEMORY trial is to compare the effects of mepolizumab with Placebo on airway physiology in patients with eosinophilic asthma

Timeline

Start

2015-11-17

Primary completion

2017-05-22

Completion

2017-05-22

Outcome

Outcome not reported

Stopped (Enrollment): “recruitment problems”

Drugs

Indications